gemtuzumab ozogamicin

Ukraine

Drugs containing this active substance

  • MYLOTARGET

    The drug is used for the treatment of newly diagnosed CD33-positive acute myeloid leukemia in adults and children (from 1 month of age), as well as for the treatment of relapsed or refractory CD33-positive acute myeloid leukemia in adults and children (from 2 years of age).

    Form: powder for concentrate for infusion solution

    Active substance Dosage
    gemtuzumab ozogamicin 4.5 mg

    ATC: L01XC05

    Manufacturer: Pharmacia and Upjohn Company LLC (secondary packaging, labeling, storage, batch release)